MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8

Oncogene

Volumn 30, Issue 7, 2011, Pages 806-821

  Fang, L ^a,b,e   Deng, Z ^a,e   Shatseva, T ^a,e   Yang, J ^c   Peng, C ^c   Du, W W ^a   Yee, A J ^a   Ang, L C ^d   He, C ^b   Shan, S W ^a,e   Yang, B B ^a,e  

^a Sunnybrook Health Sciences Centre   (Canada)

^b JILIN UNIVERSITY   (China)

^c YORK UNIVERSITY   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

angiogenesis; integrin; microRNA; siRNA; tumorigenesis

Indexed keywords

BETA INTEGRIN; MICRORNA; MICRORNA 93; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL GROWTH; CELL MIGRATION; CELL SPREADING; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR GROWTH;

ANIMALS; ASTROCYTOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; GENE SILENCING; HUMANS; INTEGRIN BETA CHAINS; MICE; MICE, NUDE; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; NERVOUS SYSTEM NEOPLASMS; RNA, SMALL INTERFERING;

EID: 79951810604     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.465     Document Type: Article

References (39)

1. Aguda BD, Kim Y, Piper-Hunter MG, Friedman A, Marsh CB. (2008). MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc Natl Acad Sci USA 105: 19678-19683.
2. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L et al. (2008). The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 14: 1271-1277.
3. Bullitt E, Lin NU, Smith JK, Zeng D, Winer EP, Carey LA et al. (2007). Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study. Radiology 245: 824-830. (Pubitemid 350127353)
4. Cambier S, Gline S, Mu D, Collins R, Araya J, Dolganov G et al. (2005). Integrin alpha(v)beta8-mediated activation of transforming growth factor-beta by perivascular astrocytes: an angiogenic control switch. Am J Pathol 166: 1883-1894. (Pubitemid 40734410)
5. Cambier S, Mu DZ, O'Connell D, Boylen K, Travis W, Liu WH et al. (2000). A role for the integrin alphavbeta8 in the negative regulation of epithelial cell growth. Cancer Res 60: 7084-7093. (Pubitemid 32059188)
6. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E et al. (2006). Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065. (Pubitemid 44325933)
7. Du L, Schageman JJ, Subauste MC, Saber B, Hammond SM, Prudkin L et al. (2009). miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 7: 1234-1243.
8. Fjellbirkeland L, Cambier S, Broaddus VC, Hill A, Brunetta P, Dolganov G et al. (2003). Integrin alphavbeta8-mediated activation of transforming growth factor-beta inhibits human airway epithelial proliferation in intact bronchial tissue. Am J Pathol 163: 533-542. (Pubitemid 36909415)
9. Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M et al. (2008). Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS ONE 3: e2236.
10. Hagendoorn J, Tong R, Fukumura D, Lin Q, Lobo J, Padera TP et al. (2006). Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res 66: 3360-3364.
11. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632. (Pubitemid 41541436)
12. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. (2005). A microRNA polycistron as a potential human oncogene. Nature 435: 828-833. (Pubitemid 40839734)
13. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, Kunz-Schughart LA. (2010). Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 148: 3-15.
14. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C et al. (2008). Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 132: 860-874. (Pubitemid 351312808)
15. Landais S, Landry S, Legault P, Rassart E. (2007). Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 67: 5699-5707. (Pubitemid 46985002)
16. Lee DY, Deng Z, Wang CH, Yang BB. (2007). MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Natl Acad Sci USA 104: 20350-20355.
17. Lee DY, Shatseva T, Jeyapalan Z, Du WW, Deng Z, Yang BB. (2009). A 3′-untranslated region (30UTR) induces organ adhesion by regulating miR-199a* functions. PLoS ONE 4: e4527.
18. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J et al. (2003). The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419. (Pubitemid 37187272)
19. Lee YS, Nakahara K, Pham JW, Kim K, He Z, Sontheimer EJ et al. (2004). Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 117: 69-81. (Pubitemid 38469899)
20. Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG et al. (2009). Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci 100: 1234-1242.
21. Mansfield JH, Harfe BD, Nissen R, Obenauer J, Srineel J, Chaudhuri A et al. (2004). MicroRNA-responsive 'sensor' transgenes uncover Hoxlike and other developmentally regulated patterns of vertebrate microRNA expression. Nat Genet 36: 1079-1083.
22. Matsubara H, Takeuchi T, Nishikawa E, Yanagisawa K, Hayashita Y, Ebi H et al. (2007). Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26: 6099-6105. (Pubitemid 47373805)
23. Mendell JT. (2008). miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
24. Novotny GW, Sonne SB, Nielsen JE, Jonstrup SP, Hansen MA, Skakkebaek NE et al. (2007). Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster. Cell Death Differ 14: 879-882. (Pubitemid 46444526)
25. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S et al. (2004). Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64: 3087-3095. (Pubitemid 38581408)
26. Petrocca F, Vecchione A, Croce CM. (2008a). Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 68: 8191-8194.
27. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I et al. (2008b). E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286. (Pubitemid 351318375)
28. Shan SW, Lee DY, Deng Z, Shatseva T, Jeyapalan Z, Du WW et al. (2009). MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat Cell Biol 11: 1031-1038.
29. Sharma A, Kumar M, Aich J, Hariharan M, Brahmachari SK, Agrawal A et al. (2009). Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a. Proc Natl Acad Sci USA 106: 5761-5766.
30. Sylvestre Y, De Guire V, Querido E, Mukhopadhyay UK, Bourdeau V, Major F et al. (2007). An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282: 2135-2143. (Pubitemid 47076740)
31. Takakura S, Mitsutake N, Nakashima M, Namba H, Saenko VA, Rogounovitch TI et al. (2008). Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci 99: 1147-1154. (Pubitemid 351676626)
32. Tomari Y, Zamore PD. (2005). Perspective: machines for RNAi. Curr Biol 15: R61-R64.
33. Uziel T, Karginov FV, Xie S, Parker JS, Wang YD, Gajjar A et al. (2009). The miR-17∼92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci USA 106: 2812-2817.
34. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ et al. (2008). Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875-886. (Pubitemid 351312807)
35. Wang CH, Lee DY, Deng Z, Jeyapalan Z, Lee SC, Kahai S et al. (2008a). MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS ONE 3: e2420.
36. Wang Q, Li YC, Wang J, Kong J, Qi Y, Quigg RJ et al. (2008b). miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130. Proc Natl Acad Sci USA 105: 2889-2894. (Pubitemid 351723639)
37. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J et al. (2008). Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9: 405-414. (Pubitemid 351405110)
38. Yeung ML, Yasunaga J, Bennasser Y, Dusetti N, Harris D, Ahmad N et al. (2008). Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res 68: 8976-8985.
39. Zheng PS, Wen J, Ang LC, Sheng W, Viloria-Petit A, Wang Y et al. (2004). Versican/PG-M G3 domain promotes tumor growth and angiogenesis. FASEB J 18: 754-756.